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Abstract
Objective To date, only few studies have evaluated the
impact of ureteral stenting prior to ureterorenoscopy. This
study is to clarify the role of preoperative ureteral stenting
in the treatment for ureteral stones.
Methods We retrospectively reviewed 550 ureterorenos-
copies from 1998 to 2008. Patients were classified into two
groups depending on whether they had a stent placed
before URS. Baseline characteristics of patients and stone
properties, stone-free rates, complications, and operation
times were compared between both groups. Subanalysis
was performed regarding stone localization. We retro-
spectively reviewed data from patient documentation,
X-ray imagery, intravenous urography, and operation
reports.
Results Baseline characteristics of patients were similar
in both groups. The majority of patients underwent stent
placement before the ureteroscopic stone treatment
(88.4%). The mean operation time in the prestented group
was longer (43.3 vs. 38.4 min). Stone-free rate of patients
with stent was 72.2%, compared to 59.4% without preop-
erative stenting. The rate of minor complications was 4.7%
with stent versus 9.4% without stent, major complications
0.6% versus 1.6%, respectively. Patients with distal ureter
stones had similar stone-free rates regardless of a stent
placement (90.1% with stent vs. 87.6% without), and no
difference in complication rates was observed (3.5% with
stent vs. 3.1% without), respectively.
Conclusions Stent placement prior to ureteroscopic stone
treatment in distal ureter is not reasonable and does not
considerably improve stone-free rates.
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Abbreviations
Ch Charrie`re, diameter of urologic instruments,
catheters, and endoscopes. 1 Ch = 1
French = 1/3 mm
DJ Double-J ureteral stent




The role of stent placement after ureterorenoscopic stone
treatment has been evaluated by many studies according to
which routine stenting after uncomplicated ureteroscopic
stone procedure is not necessary. Associated complications
such as stent migration, breakage, encrustation, urinary
tract infection, and obstruction were observed. Further-
more, a secondary cystoscopy was required for stone
removal in many cases. Clear indications exist for post-
operative stenting after ureterorenoscopy. These are among
others solitary kidney, renal insufficiency, ureteral injury,
stricture, or a large residual stone burden [3, 5, 7].
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However, only few studies have been published that
focus on preoperative double-j stenting. Although this
technique is frequently used, little is known about its
indications and results. Hence, the purpose of this study is
to clarify the role of prestenting for the procedures’ results.
Therefore, we reviewed the data of several hundred
ureterorenoscopic stone treatments.
Patients and methods
We retrospectively reviewed 550 ureterorenoscopic pro-
cedures (URS) from 474 individual patients between
January 1998 and December 2008. These patients were
classified into two groups depending on whether they had a
stent placed before URS. One group of patients had
received preoperative stent placement (group 1), whereas
the other had not (group 2). Group 1 received preoperative
stents because clinical evidence of stones or persistent
renal colics existed before the URS. Group 2 had received
URS as a diagnostic procedure to further examine tumor
suspicion, suspicion of abnormal ureter lumina, ureter
structure, or hematuria located in the ureter. With all
included patients in group 2, stones were incidentally
found; meanwhile, no other abnormality was detected
in the URS. All URS were performed or supervised by
specialists in the Department of Urology, University of
Goettingen, Germany.
Stones visible in X-ray imaging or intravenous urogra-
phy were measured for their linear diameter, and stone
location was noted. Both determined the choice of the
ureterorenoscope. We used semirigid (OES PRO,
Olympus) and flexible ureterorenoscopes (URF-P5 and
DUR-8 Elite, Olympus).
Preoperatively as a rule 6 Ch, double-j ureteral stents
were used. Depending on the patient’s size, the stents were
between 26 and 30 cm long. All stents were placed using a
21 Ch endoscope (Olympus). Anesthetization was done
facultatively with Midazolam (Dormicum) or Piritramid
(Dipidolor). Nephrostomy was necessary when contrast
medium instilled into the ureter showed obstructing ure-
teral calculi. All stents were removed at the beginning of
the ureteroscopic procedure before stone removal.
We retrospectively reviewed data from patient docu-
mentation, X-ray imagery, intravenous urography, and
operation reports. The statistics were done with ‘‘Open
Office Calc’’ (version 3.1) and ‘‘R’’ (version 2.9.2).
Results
Both groups (with and without stent placement) had similar
features concerning the patients’ age, gender ratio, and
diameter of stones (Table 1). More distal ureter stones and
stones in a single urinary tract location were observed in
the unstented group. The most striking difference between
both groups was the total amount of performed procedures.
Patients underwent stent placement prior to stone treatment
in 88.4% of all 550 ureterorenoscopies.
A successful stone-free status was achieved when all
endoscopically or radiographically visible stone fragments
had been removed completely. The operation time was
extended by 4.9 min when prestented patients were treated
(43.3 vs. 38.4 min). Patients who underwent stent place-
ment had a higher stone-free rate than nonstented patients
(72.2%, n = 351 vs. 59.4%, n = 38). Stented patients had
less complications than patients without preoperative stent
placement (minor complications: 4.7%, n = 23 vs. 9.4%,
n = 6, major complications: 0.6%, n = 3 vs. 1.6%, n = 1)
(Fig. 1). Perforations of ureter or renal pelvis were defined
as minor complications in this study together with hema-
turia and obstructive urinary flow disorders. Minor com-
plications were treated with stent placement at the end of
the procedure. Major complications were ureter avulsion,
urosepsis, and bleeding with need for blood transfusion.
Major complications required immediate and extensive
intervention in contrast to minor complications.
Considerably, more ureter perforations occurred in the
non-stented patient group. 13 ureteral perforations were
observed after 486 ureterorenoscopies with preoperative
stent placement (2.7%), compared to 6 perforations after 64
treatments without stenting (9.4%) (Table 2).
One or more stones in a single urinary tract location
were treated in 458 ureterorenoscopies (Fig. 2), whereas
stones in different locations of the urinary tract were
Table 1 Patient characteristics
DJ before URS No DJ before URS Total
Procedures 486 64 550
Age (years) 50.7 49.9 50.6
Gender
Men 336 49 385
Women 150 15 165
Stone size
Max. diameter (mm) 5.3 5.6 5.3
B5 mm 292 31 323
[5 mm B 10 mm 167 29 196
[10 mm 27 4 31
Stone location
Renal pelvis 95 8 103
Prox. ureter 59 11 70
Mid. ureter 71 10 81
Distal. ureter 172 32 204
Multiple 89 3 92
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treated in 92 procedures. Prestented patients had an
improved stone-free rate compared to non-stented patients
when the stone was located in the proximal urinary tract
(mid/proximal ureter or renal pelvis) (67.1%, n = 150 vs.
34.5%, n = 10). Less complications occurred in the prox-
imal urinary tract when patients had undergone preopera-
tive stent placement (7.1%, n = 16 vs. 17.2%, n = 5).
When distal ureter calculi were treated, the stone-free rate
was nearly the same in both groups (90.1%, n = 154 vs.
87.5%, n = 28), whereas the rate of complications was
slightly increased in the group of patients which received a
Fig. 2 Preoperative DJ-
stending in distal and proximal
urinary tract
Fig. 1 All procedures to
difference with DJ or without
DJ before URS
Table 2 Complication all procedures to difference with DJ or with-






Ureter perforation 13 6 19
Renal pelvis perforation 10 – 10
Ureter avulsion 1 – 1
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stent prior to ureterorenoscopy (3.5%, n = 6 vs. 3.1%,
n = 1) (Fig. 2).
Discussion
Although it is a frequently used technique, only few studies
have evaluated the role of ureteral stenting before urete-
rorenoscopic stone treatment. Therefore, questions about
its impact on procedures’ results and correct indications
remain unsolved. The purpose of this analysis was to
provide answers concerning results and complications of
prestenting.
The operation time of prestented patients was extended
compared to patients without stent placement before
ureterorenoscopy by 4.9 min.
In our opinion, stent extraction prior to ureteroreno-
scopic stone treatment caused the difference in operation
time between both groups. No publications could be found
concerning this issue. Chander and colleagues reported that
prestenting had no effect on the operation time of retro-
peritoneal laparoscopic pyelolithotomy. This result was not
significant and probably not relevant for the results of
ureterorenoscopic stone treatment [1].
The impact of stent placement prior to ureterorenoscopy
on the results of ureteral stone treatment has provoked
controversial discussion. Corcoran et al. and Hubert and
Palmer reviewed the impact of prestenting on the results of
ureterorenoscopy in children (\18 years). Corcoran et al.
reported that prestenting reduced additional treatments and
yielded a low complication rate after primary ureterore-
noscopy had failed. Hubert and Palmer were able to avoid
active dilatation of the ureter in all cases after stent
placement prior to ureteroscopy [2, 4]. Rubenstein et al.,
Shields et al., and Unsal et al. analyzed the impact of
preoperative stenting before ureterorenoscopy on the out-
come in adults. All three publications come to the con-
clusion that preoperative stenting is optional and not
obligatory. Rubenstein et al. and Shields et al. point out
that stent placement can result in better stone-free rates
[8–10].
Our results show that preoperative stenting considerably
improved the stone-free rates with proximal located stones
(mid/proximal ureter and renal pelvis). In contrast, the
stone-free rate of stones treated in distal ureter was not
considerably increased after preoperative stent placement
(Fig. 2).
Rubenstein and colleagues reviewed 115 ureteroreno-
scopic treatments of ureter and renal pelvis stones. The
stone-free rate of prestented patients was significantly
higher than that of patients without stent [8]. Shields et al.
reported similar results of 259 ureteroscopies for ureter
stones. Patients who had received a stent prior to
ureterorenoscopy had an increased stone-free rate although
this result was not significant [9]. Musa analyzed the
impact of prestenting on the outcome of 120 ESWL
treatments. In this study, patients with stent prior to
ureterorenoscopy had no improvement of stone-free rates
[6]. These findings are in agreement with our observations.
We found a considerably higher stone-free rate of pres-
tented patients compared to patients without stent place-
ment when the stone was located in mid/proximal ureter or
renal pelvis. However, when distal ureter stones were
treated, both groups showed nearly equal stone-free rates.
To our knowledge, there is no report available to discuss
this issue. However, Shields et al. placed stents more fre-
quently prior to ureterorenoscopy when stones in proximal
ureter were treated (51.6% stented with distal ureter stones,
79.2% stented with stones in renal pelvis). The resulting
considerable stone-free rate then was 83.3% for stones in
renal pelvis [9].
In our study, prestented patients had fewer complica-
tions than patients who did not receive a stent before stone
treatment (minor complications 4.7% vs. 9.4%, major
complications 0.6% vs. 1.6%) (Fig. 1). Especially, ureter
perforations occurred more frequently in the non-stented
group (2.7% vs. 9.4%). Analysis of the subgroups revealed
that patients without stent who were treated for stones in
mid/proximal ureter and renal pelvis had more complica-
tions than stented patients (17.2% vs. 7.1%). However,
when distal ureter stones were treated, there was no dif-
ference between both groups regarding the complication
rate (3.1% in the nonstented group vs. 3.5% in the pres-
tented group, respectively) (Fig. 2).
Rubenstein et al. reported hydronephrosis and ureter
stricture as complications in one case in both groups (36
patients stented and 97 patients not stented prior to urete-
rorenoscopy). In addition, patients without stent had a
subcapsular hematoma in one case and delayed voiding
revealed on IVU in two cases. On a generally low com-
plication level, there was no significant difference in the
complication rate between both groups [8]. Hubert and
Palmer analyzed the effect of preoperative stenting on the
results of ureteroscopic stone treatment in infants. The
authors reported no complications at all in both groups,
stented and not [4]. However, no further subanalysis was
performed regarding stone location and complications. To
our knowledge, there is no report available discussing this
issue.
Conclusion
We reviewed literature and did not find any association
between preoperative stenting and an increased complica-
tion rate. Prestented patients who were treated for mid/
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proximal ureter stones had improved stone-free rates and
less complications compared to patients without stent. In
contrast to this placing, a stent prior to the treatment for
distal stones by URS did not result in a benefit for the
treated patients. This leads to the conclusion that preop-
erative stent placement for the treatment for distal ureter
stones is not reasonable.
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